COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,043 Articles (22,627 medRxiv, 8,416 bioRxiv)

Most recent first Previous |  Page 111: Articles 1101-1110  | Next

Bridging immunotypes and enterotypes using a systems immunology approach
Affaticati, F., Ha, M., Gehrmann, T., De Boeck, I., Kuznetsova, M., Vandoren, R., Van Deuren, V., Jansens, H., De Reu, H., Schippers, J., Peeters, K., Bartholomeus, E., VanIerssel, S., Coenen, S., Naesens, R., Arien, K., Vercauteren, K., Vlieghe, E., Beutels, P. M. L., Van Damme, P., Goossens, H., Lion, E., Suls, A., Lebeer, S., Laukens, K., Meysman, P., Ogunjimi, B.
10.1101/2024.11.29.625344 — Posted: 2024-11-29
Tracking Immunity: Increased number of COVID-19 boosters increases the longevity of anti-RBD and anti-RBD neutralizing antibodies.
Hou, C.-W., Williams, S., Boyle, V., Roeder, A., Bobbett, B., Garcia, I., Caruth, G., Magee, M., Chung, Y., Lake, D., LaBaer, J., Murugan, V.
10.1101/2024.11.25.24317883 — Posted: 2024-11-28
Estimating the risk of post-COVID condition (PCC) in deprived communities, migrants and ethnic minorities in England
Fong, W. L. E., Beale, S., Nguyen, V. G., Kovar, J., Yavlinksy, A., Hayward, A. C., Abubakar, I., van Kuijk, S. M., Aldridge, R. W.
10.1101/2024.11.26.24317965 — Posted: 2024-11-28
Preparing for Disease X requires CLARITY, Lessons learned from COVID-19: A systematic review
Boivin, M., Bourbeau, J., Sedeno, M. F., Horvat, E., Li, P.-Z., Noueihed, B., Connelly, K. A., Jain, A., Lin, P., Mazer, B., Saposnik, G., Strain, D.
10.1101/2024.11.27.24317926 — Posted: 2024-11-28
Risk of Severe Outcomes From COVID-19 in Immunocompromised People During the Omicron Era: ASystematic Review and Meta-Analysis
Chapman, A., Berenbaum, F., Curigliano, G., Pliakas, T., Sheikh, A., Abduljawad, S.
10.1101/2024.11.25.24317895 — Posted: 2024-11-28
The IL-33/ST2 signaling axis drives pathogenesis in acute SARS-CoV-2 infection
Fleming, C., McSorley, H. J., Allen, J. E., Petri, W. A.
10.1101/2024.11.27.625579 — Posted: 2024-11-28
Real-world effectiveness of NVX-CoV2373 and BNT162b2 mRNA COVID-19 vaccination in South Korea
Gwak, E., Choe, S.-A., Kim, K., Bolormaa, E., Fix, J., Vadivale, M., Rousculp, M. D., Choe, Y. J.
10.1101/2024.11.26.24317925 — Posted: 2024-11-27
Demographic Representation of a Decentralized Long COVID Trial: A Comparison with the 2023 National Health Interview Survey
Sawano, M., Warner, F., Henriquez, Y., Bhattacharjee, B., Iwasaki, A., Krumholz, H. M.
10.1101/2024.11.25.24317941 — Posted: 2024-11-27
Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomized controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings
Hosseini, B., Condon, A., da Costa, B. R., Daley, P., Greiver, M., Jüni, P., Lee, T. C., McBrien, K., McDonald, E. G., Murthy, S., Selby, P., Andrew, M., Aubrey-Bassler, K., Barber, D., Barrett, B., Butler, C., Crampton, N., Dahrouge, S., Damji, A., Fowler, R., Garies, S., Hudon, C., Hulme, J., Isenor, J., Jenkins, D., Lall, R., LeBlanc, A., Leong, C., Little, P., Lofters, A., Logsetty, S., Lother, S., Lussier, M.-T., MacLaren, L., Mangin, D., Marshall, E., Marshall, J., McCracken, R., Moineddin, R., Orava, B., Paquette, J.-S., Park, J. J. H., Persaud, N., Rac, V., Ramsden, V., Rayner, J., Ra
10.1101/2024.11.25.24317904 — Posted: 2024-11-27
Identification and genomic characterization of a novel bisegmented coronavirus in the lesser panda
chen, x., Guo, H., Zhou, N., Shi, Z., Cui, X., Dong, T., Qin, M., Liang, X., Shan, F., Wang, H., Zuo, Q., Peng, S., You, W., Irwin, D. M., Chen, W., Zeng, L., Ding, C., Shen, Y.
10.1101/2024.11.26.625429 — Posted: 2024-11-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).